Katharina Rahmel-Stein

PhD Student

Contact

+49 (0)511-220027-216katharina.rahmel-stein@twincore.de

Research Lab

Kalinke Lab

Experimental Infection Research

Publications

2026The Journal of Clinical Investigation : e203540

Immune Cell-Specific SMN Expression and Sustained Immune Alterations in Treated Spinal Muscular Atrophy

Tapken I, Rahmel-Stein K, Ehlers C, Cieri F, Detering N, Schüning T, Bjelica B, Mindermann C, Neuhoff S, Schmitt L, Leo M, Hagenacker T, Illsinger S, Di Schiavi E, Graalmann T, Petri S, Kalinke U, Claus P

2026The Lancet. Infectious Diseases : S1473-3099(26)00407-X

Pseudovirus-based analysis of host cell entry and vaccine-induced neutralisation of Bundibugyo virus

Hoffmann M, Shandheep A, Pavlou A, Rahmel-Stein K, Ly M, Chen N, Moor N, Moldenhauer A, Drosten C, Kalinke U, Addo M, Pöhlmann S

Posts

The two scientists, Katharina Rahmel-Stein and Dr Ines Tapken, are standing in front of a flow cytometer wearing white lab coats.

09/24/2026

New findings on spinal muscular atrophy

Researchers investigate the impact on the immune system.

The TWINCORE researchers Aparna Shandheep, Ulrich Kalinke, Katharina Rahmel-Stein and Andreas Pavlou (from left to right)

08/20/2026

Antibodies produced following the Ebola vaccination neutralise the current Bundibugyo virus variant

A team of researchers from Hamburg, Berlin, Göttingen and Hannover has provided evidence of possible cross-protection offered by an already authorised Zaire Ebola virus vaccine.

Show all posts